2023 Investor Materials

Annual Report

Annual Report

View an enhanced version of our
Annual Report.

Proxy Statement

Proxy Statement

View an enhanced version of our
Proxy Statement. 

About Cryo-Cell

Cryo-Cell International Inc., founded in 1989, is the world’s first private cord blood bank. Cryo-Cell is internationally recognized as the industry leader by its leading-edge processing technologies to capture the most viable cell types and adherence to the highest accreditation standards in cryopreservation procedures, resulting in the most optimal cord blood and tissue stem cell collections for our families. We offer private and public stem cell banking programs to provide expectant parents with the best options available in cryopreservation services. In addition, Cryo-Cell intends to open an infusion clinic(s) to administer cellular therapies under FDA-approved INDs to treat patients with cerebral palsy, autism, and traumatic brain injuries, through an exclusive license agreement with Duke University. Patients do not have to be customers of Cryo-Cell’s cord blood and cord tissue banking services to have access to treatment.

We invite you to learn more about how Cryo-Cell stands apart from other cord blood banks. We know you will join the over 500,000 parents from 87 countries who have selected Cryo-Cell to safeguard their families' future health. We provide families with a variety of plans and services to help them protect what matters most.

For more information, please visit www.cryo-cell.com.